Source: BillionPhotos.
  • Telo Genomics is announcing a $2 million private placement to further its multiple myeloma initiatives
  • The funds will go toward launching Telo-MM, the company’s lead product to treat multiple myeloma, as well as advancing related research with the Mayo Clinic
  • The capital will also advance the company’s pursuit of ISO 15189 certification and certified Clinical Laboratory Improvement Amendments accreditation
  • Telo Genomics is a biotech company pioneering a comprehensive DNA-based platform with powerful applications and prognostic solutions
  • Telo Genomics (TSXV:TELO) is unchanged trading at $0.30 per share

Telo Genomics is announcing a $2 million private placement to further its multiple myeloma initiatives.

Telo will use the proceeds to fund:

  • The commercial launch of Telo-MM, its lead product, which is being developed to provide important, actionable information to medical professionals in the treatment of multiple myeloma, a form of blood cancer
  • Its ongoing collaborative studies with the Mayo Clinic in multiple myeloma
  • ISO 15189 certification and certified Clinical Laboratory Improvement Amendments accreditation
  • General working capital purposes

The non-brokered private placement will offer units at $0.25 each.

Each unit consists of one common share and one-half of one non-transferable common share purchase warrant.

Each warrant will entitle the holder to acquire one common share for $0.40 for 24 months from the date of issuance.

All securities issued will be subject to a four-month hold period from the date of issuance.

Telo Genomics is a biotech company pioneering a comprehensive DNA-based platform with powerful applications and prognostic solutions. These include liquid biopsies and related technologies in oncology (multiple myeloma) and neurological diseases (Alzheimer’s Disease). 

Telo Genomics (TSXV:TELO) is unchanged trading at $0.30 per share.

The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.


More From The Market Online

Record new users sign up to Bitcoin Well after popular YouTube feature

Non-custodial crypto business Bitcoin Well (TSXV:BTCW) announces it has signed up a record number of new users to its platform.

Nerds On Site launches AI subsidiary

Nerds on Site (CSE:NERD) reveals the launch of a new artificial intelligence subsidiary called NOS Technical Services.

Activist investor seeks to overhaul WonderFi board

KAOS Capital, an activist investor and major WonderFi (TSX:WNDR) shareholder, plans to propose five nominations to the crypto stock's board.

Energy management stock signs credit agreement and reduces debt

Kontrol Technologies (NEO:KNR) announces it has signed an amended credit agreement with its secured lender and exited forbearance.